Groupe Productlife Sas, headquartered in France, is a leading player in the pharmaceutical and healthcare industry, specialising in regulatory affairs, quality assurance, and product lifecycle management. Founded in 2006, the company has established a strong presence across Europe and beyond, providing tailored solutions that enhance compliance and streamline processes for clients in the life sciences sector. With a commitment to innovation, Groupe Productlife Sas offers unique services that include strategic consulting and comprehensive support for product registration and market access. Their expertise has positioned them as a trusted partner for numerous pharmaceutical companies, contributing to their notable achievements in regulatory success and client satisfaction. As a result, Groupe Productlife Sas continues to solidify its reputation as a key contributor to the evolving landscape of healthcare and pharmaceuticals.
How does Groupe Productlife Sas's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Groupe Productlife Sas's score of 32 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Groupe Productlife Sas reported total carbon emissions of approximately 5,700,000 kg CO2e, with emissions distributed across various scopes: 45,890 kg CO2e (Scope 1), 87,770 kg CO2e (Scope 2), and a significant 5,650,170 kg CO2e (Scope 3). The Scope 3 emissions primarily stemmed from purchased goods and services, accounting for the majority of their carbon footprint. The company has set ambitious reduction targets, aiming for a 5% reduction in year-over-year emissions per employee from 2023 to 2028 (Scope 1). Additionally, they are committed to reducing their GHG emissions related to activities in the Transport sector by 30% by 2030, compared to 2015 levels, encompassing both Scope 1 and Scope 2 emissions. Groupe Productlife Sas is actively engaged in climate commitments, having established near-term targets and demonstrating a commitment to sustainability within the pharmaceuticals, biotechnology, and life sciences sector. The company is not currently committed to a net-zero target but remains focused on significant emissions reductions in the coming years.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 1,216,802,580 | 000,000,000 | 0,000,000,000 | 00,000 |
| Scope 2 | 4,176,972,860 | 0,000,000,000 | 0,000,000,000 | 00,000 |
| Scope 3 | - | - | 0,000,000 | 0,000,000 |
Groupe Productlife Sas's Scope 3 emissions, which decreased by 16% last year and decreased by approximately 16% since 2021, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 100% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Groupe Productlife Sas has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Common questions about Groupe Productlife Sas's sustainability data and climate commitments